HeartSciences Inc. - Common Stock (HSCS)
Healthcare › Orthopedic, Prosthetic & Surgical Appliances & Supplies
Price History
Feb 9, 2026 — Jul 6, 2026Investment Snapshot
- P/B of 2.01 — trading above book value
- Piotroski F-Score 1/9 — signs of financial weakness
- Loss-making — negative ROE of -336.6%
- Revenue declining 77% annually
HeartSciences Inc. - Common Stock (HSCS) is a Healthcare company operating in Orthopedic, Prosthetic & Surgical Appliances & Supplies, listed on the NASDAQ , with a market capitalisation of $5 million . Key value metrics: P/B ratio 2.01, Piotroski F-Score 1 out of 9 .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 4 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
HeartSciences Inc. - Common Stock — Fundamental Analysis Summary
On financial health, HSCS shows a weak Piotroski F-Score of 1/9, a signal of deteriorating financial health, and negative return on equity of -336.6% (sector average: -20.6%), and manageable leverage with a debt-to-equity ratio of 0.43.
StockPik's composite Value Score for HSCS is 35/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
HSCS reports a solid gross margin of 59.1% (sector average: 39.4%) and a negative operating margin of -190,968.6%.
HSCS shows revenue declining at 77% year-over-year, with earnings declining at 33%.